価格表

在庫・価格 : 2025年07月22日 19時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
VEGI/TNFSF15, Mouse, Recombinant <TL1A>
データシート
1896-TL-010 RSDアールアンドディー システムズ
R&D Systems, Inc.
10 μg ¥71,000
(未発注)
追加

在庫・価格 : 2025年07月22日 19時43分 現在

VEGI/TNFSF15, Mouse, Recombinant <TL1A>

  • 商品コード:1896-TL-010
  • メーカー:RSD
  • 包装:10μg
  • 価格: ¥71,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Kim MY et al. Neonatal and adult CD4+ CD3- cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J. Immunol. 2006 Sep;177(5):3074-81
Kim MY et al
2006/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
2 Kim MY et al. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology 2008 Jun;124(2):166-74
Kim MY et al
2008/01/01
Species: Mouse, Application: Bioassay, Whole Cells PubMed
3 Meylan F et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 2008 Jul;29(1):79-89
Meylan F et al
2008/01/01
Species: Mouse, Application: Bioassay, Whole Cells PubMed
4 Mueller AM et al. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid. J. Neuroimmunol. 2009 Apr;209(1-2):57-64
Mueller AM et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 Kayamuro H et al. TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant. Biochem. Biophys. Res. Commun. 2009 Jul;384(3):296-300
Kayamuro H et al
2009/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
6 Jones GW et al. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J. 2011 Jan;25(1):409-19
Jones GW et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Pobezinskaya YL et al. The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling. J. Immunol. 2011 May;186(9):5212-6
Pobezinskaya YL et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Freeman BE et al. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012 Jun;109(25):9971-6
Freeman BE et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
9 Wang X et al. TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses. J. Immunol. 2013 Dec;191(11):5420-9
Wang X et al
2013/01/01
Application: cell culture, Sample Type: whole cells PubMed
10 Yu X et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol 2014 May;7(3):730-40
Yu X et al
2014/01/01
Application: In vivo injection, Sample Type: In Vivo PubMed
11 Longman RS et al. CX&#x2083;CR1&#x207A; mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 2014 Jul;211(8):1571-83
Longman RS et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Twohig JP et al. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4&#x207A; and CD8&#x207A; T-cell immunity. FASEB J. 2012 Aug;26(8):3575-86
Twohig JP et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
13 Holmkvist P et al. IL-18R&#x3B1;-deficient CD4(+) T&#xA0;cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur. J. Immunol. 2016 Jun;46(6):1371-82
Holmkvist P et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
14 Jia LG et al. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection. J. Immunol. 2016 Jul;197(1):377-86
Jia LG et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
15 Zhao Y et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun 2016 Aug;7:12368
Zhao Y et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Kim MY et al. Neonatal and adult CD4+ CD3- cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J. Immunol. 2006 Sep;177(5):3074-81
    Kim MY et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kim MY et al. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology 2008 Jun;124(2):166-74
    Kim MY et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Meylan F et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 2008 Jul;29(1):79-89
    Meylan F et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Mueller AM et al. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid. J. Neuroimmunol. 2009 Apr;209(1-2):57-64
    Mueller AM et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kayamuro H et al. TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant. Biochem. Biophys. Res. Commun. 2009 Jul;384(3):296-300
    Kayamuro H et al
    2009/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Jones GW et al. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J. 2011 Jan;25(1):409-19
    Jones GW et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Pobezinskaya YL et al. The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling. J. Immunol. 2011 May;186(9):5212-6
    Pobezinskaya YL et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Freeman BE et al. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012 Jun;109(25):9971-6
    Freeman BE et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wang X et al. TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses. J. Immunol. 2013 Dec;191(11):5420-9
    Wang X et al
    2013/01/01
  • 備考:
    Application: cell culture, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Yu X et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol 2014 May;7(3):730-40
    Yu X et al
    2014/01/01
  • 備考:
    Application: In vivo injection, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Longman RS et al. CX&#x2083;CR1&#x207A; mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 2014 Jul;211(8):1571-83
    Longman RS et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Twohig JP et al. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4&#x207A; and CD8&#x207A; T-cell immunity. FASEB J. 2012 Aug;26(8):3575-86
    Twohig JP et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Holmkvist P et al. IL-18R&#x3B1;-deficient CD4(+) T&#xA0;cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur. J. Immunol. 2016 Jun;46(6):1371-82
    Holmkvist P et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Jia LG et al. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection. J. Immunol. 2016 Jul;197(1):377-86
    Jia LG et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Zhao Y et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun 2016 Aug;7:12368
    Zhao Y et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed